GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
3.660
-0.020 (-0.54%)
At close: Aug 10, 2026, 4:00 PM EDT
3.589
-0.071 (-1.93%)
After-hours: Aug 10, 2026, 7:55 PM EDT

GoodRx Holdings Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, GoodRx Holdings stock has a consensus rating of "Hold" and an average price target of $3.86. The average 1-year stock price forecast is 5.46% higher than the current stock price, while the lowest is $2.50 (-31.69%) and the highest is $5.00 (+36.61%).

Price Target: $3.86 (+5.46%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$2.50$3.86$4.00$5.00
Change-31.69%+5.46%+9.29%+36.61%

Analyst Ratings

The average analyst rating for GoodRx Holdings stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy444444
Buy111111
Hold888887
Sell222222
Strong Sell000000
Total151515151514

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Citi
Citi
Buy
Reiterates
$4$5
BuyReiterates$4$5+36.61%Aug 10, 2026
TD Cowen
TD Cowen
Buy
Maintains
$4$5
BuyMaintains$4$5+36.61%Aug 10, 2026
Raymond James
Raymond James
Buy
Maintains
$4.5
BuyMaintains$4.5+22.95%Aug 7, 2026
Morgan Stanley
Morgan Stanley
Hold
Reiterates
$3$4
HoldReiterates$3$4+9.29%Aug 7, 2026
Goldman Sachs
Goldman Sachs
Hold
Reiterates
$3.5$4
HoldReiterates$3.5$4+9.29%Aug 7, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
795.07M
from 796.85M
Decreased by -0.22%
Revenue Next Year
832.52M
from 795.07M
Increased by 4.71%
EPS This Year
0.31
from 0.35
Decreased by -11.99%
EPS Next Year
0.36
from 0.31
Increased by 16.27%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
745.42M766.55M750.27M792.32M796.85M795.07M
Revenue Growth
35.36%2.84%-2.13%5.61%0.57%-0.22%
Gross Profit
698.71M701.48M687.84M744.11M739.26M715.89M
Gross Margin
93.73%91.51%91.68%93.91%92.77%90.04%
Operating Income
13.41M19.80M49.50M86.20M106.20M169.54M
Net Income
-25.25M-32.83M-8.87M16.39M30.44M26.28M
EPS
----0.350.31
EPS Growth
----2.94%-11.99%
Forward PE
267.21167.96186.5627.0418.8511.88
Free Cash Flow
147.80M95.77M113.28M116.77M81.94M97.78M
No. Analysts
-----12
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High802.4M
Avg795.1M
Low777.9M

Revenue Growth

Revenue Growth202620272028
High
0.7%
Avg
-0.2%
Low
-2.4%

EPS Forecast

EPS202620272028
High0.34
Avg0.31
Low0.29

EPS Growth

EPS Growth202620272028
High
-2.9%
Avg
-12.0%
Low
-17.1%